Skip to content

Personalized Neuronavigation TMS for Treating Depression and Its Neural Mechanisms

Personalized Neuronavigation TMS for Treating Depression and Its Neural Mechanisms

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400091784
Enrollment
Unknown
Registered
2024-11-04
Start date
2024-11-06
Completion date
Unknown
Last updated
2024-11-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Depression

Interventions

Sponsors

The Third Hospital of Inner Mongolia Autonomous Region
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patients diagnosed with depression by DSM-5; 17 items Hamilton Depression Scale (HAMD-17)>17; Patients were required to understand the study and sign an informed consent.

Exclusion criteria

Exclusion criteria: 1. Patients with metal or electronic instruments in the body, such as cardiac pacemakers, nerve stimulators, artificial metal heart valves, metal foreign bodies in the eye, inner ear implants, metal prostheses, metal joints, and ferromagnetic foreign bodies in the body; 2. People with brain diseases and other serious physical diseases; 3. Patients with other head MRI contraindications; 4. Pregnant, breastfeeding or planning pregnancy during the trial; 5. Acute suicides with suicidal behavior requiring urgent intervention; 6. Patients with other severe mental illnesses, such as schizophrenia, bipolar disorder, etc.

Design outcomes

Primary

MeasureTime frame
17-Hamilton Depression Scale;

Secondary

MeasureTime frame
Montgomery-Asberg Depression Rating Scale;Hamilton Anxiety Scale;Patient Health Questionnaire; Snaith-Hamilton Pleasure Scale;Pittsburgh sleep quality index;Insomnia Severity Index;Digit Symbol Substitution Test;Functional connection;local activity metrics;

Countries

China

Contacts

Public ContactDongsheng Lv

The Third Hospital of Inner Mongolia Autonomous Region

dongshenglv@163.com+86 138 4881 0596

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026